Disease-related patterns of in vivo pathology in Corticobasal syndrome.
Disease-related patterns of in vivo pathology in Corticobasal syndrome.
复制标题
DOI:
10.1007/s00259-018-4104-2
复制
发表时间:
2018-12
影响因子:
9.1
通讯作者:
Alzheimer’s Disease Neuroimaging Initiative
中科院分区:
文献类型:
--
作者:
Niccolini F;Wilson H;Hirschbichler S;Yousaf T;Pagano G;Whittington A;Caminiti SP;Erro R;Holton JL;Jaunmuktane Z;Esposito M;Martino D;Abdul A;Passchier J;Rabiner EA;Gunn RN;Bhatia KP;Politis M;Alzheimer’s Disease Neuroimaging Initiative
To assess disease-related patterns of in vivo pathology in 11 patients with Corticobasal Syndrome (CBS) compared to 20 healthy controls and 33 mild cognitive impairment (MCI) patients due to Alzheimer’s disease. We assessed tau aggregates with [18F]AV1451 PET, amyloid-β depositions with [18F]AV45 PET, and volumetric microstructural changes with MRI. We validated for [18F]AV1451 standardised uptake value ratio (SUVRs) against input functions from arterial metabolites and found that SUVRs and arterial-derived distribution volume ratio (DVRs) provide equally robust measures of [18F]AV1451 binding. CBS patients showed increases in [18F]AV1451 SUVRs in parietal (P < 0.05) and frontal (P < 0.05) cortices in the affected hemisphere compared to healthy controls and in precentral (P = 0.008) and postcentral (P = 0.034) gyrus in the affected hemisphere compared to MCI patients. Our data were confirmed at the histopathological level in one CBS patient who underwent brain biopsy and showed sparse tau pathology in the parietal cortex co-localizing with increased [18F]AV1451 signal. Cortical and subcortical [18F]AV45 uptake was within normal levels in CBS patients. In parietal and frontal cortices of the most affected hemisphere we found also grey matter loss (P < 0.05), increased mean diffusivity (P < 0.05) and decreased fractional anisotropy (P < 0.05) in CBS patients compared to healthy controls and MCI patients. Grey matter loss and white matter changes in the precentral gyrus of CBS patients were associated with worse motor symptoms. Our findings demonstrate disease-related patterns of in vivo tau and microstructural pathology in the absence of amyloid-β, which distinguish CBS from non-affected individuals and MCI patients. The online version of this article (10.1007/s00259-018-4104-2) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
7.1
作者:
Lowe VJ;Curran G;Fang P;Liesinger AM;Josephs KA;Parisi JE;Kantarci K;Boeve BF;Pandey MK;Bruinsma T;Knopman DS;Jones DT;Petrucelli L;Cook CN;Graff-Radford NR;Dickson DW;Petersen RC;Jack CR Jr;Murray ME
通讯作者:
Murray ME
DOI:
10.1038/s41531-017-0012-6
发表时间:
2017
期刊:
NPJ Parkinson's disease
影响因子:
--
作者:
Albrecht F;Bisenius S;Morales Schaack R;Neumann J;Schroeter ML
通讯作者:
Schroeter ML
影响因子:
14
作者:
Sander, Kerstin;Lashley, Tammaryn;Arstad, Erik
通讯作者:
Arstad, Erik
影响因子:
6.3
作者:
LOGAN, J;FOWLER, JS;CHRISTMAN, DR
通讯作者:
CHRISTMAN, DR
影响因子:
5.7
作者:
Malone IB;Leung KK;Clegg S;Barnes J;Whitwell JL;Ashburner J;Fox NC;Ridgway GR
通讯作者:
Ridgway GR